CLBS Price Targets and Analyst Ratings NASDAQ:CLBS
CLBS Forecast. What You Should Know.
CLBS Historical Ratings and Targets
About Caladrius Biosciences
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysf... CLBS Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.